Wed, Jan. 28, 4:03 PM
- A study done by researchers from New York and Columbia Universities found that premiums were slightly higher for policies offered on state-run health exchanges where there were higher numbers of competitors, precisely the opposite effect that supposedly characterizes more intense competition.
- Overall, average monthly premiums were $5.71 higher per additional insurer (p<0.001). In addition, average monthly premiums were $3.18 higher per additional insurer for identical plans offered.
- The analysis focused on the prices for each unique insurance plan offered on the exchanges in each geographic rating area. The number of rating areas varied widely in the 34 states examined, from only one in NJ, NH and DE to 67 in FL.
- The authors acknowledge that the higher premiums may be due to higher cost areas (urban vs rural) where more insurers are located rather than a lack of competition.
- Related tickers: (NYSE:AFL) (NYSE:AIG) (NYSE:AET) (NYSE:CI) (NYSE:CNC) (NYSE:UNH) (NYSE:ANTM) (NYSE:MOH) (NYSE:HNT) (NYSE:HUM) (NYSE:WCG) (NASDAQ:MGLN)
Dec. 10, 2014, 5:48 PM
- Aetna (NYSE:AET) -1% AH after issuing a weaker than expected earnings forecast for next year, saying it expects to make at least $6.90/share on revenue of at least $62B vs. analyst consensus estimates of $7.17/share on $61.7B in revenue.
- AET reaffirms guidance for FY 2014 adjusted EPS of $6.60-$6.70 vs $6.65 analyst consensus, on expected operating revenues of $57B-$58B.
Nov. 21, 2014, 3:07 PM
Nov. 21, 2014, 2:34 PM
Nov. 3, 2014, 9:10 AM
- Aetna (NYSE:AET) acquires privately-held bswift, a provider of a technology platform that offers a retail shopping experience for health insurance exchanges and employers nationwide. It also provides benefits administration technology and services to employers.
- The purchase price is ~$400M and will be funded with cash on hand.
Oct. 28, 2014, 10:09 AM
- Aetna (AET +0.6%) Q3 results: Revenues: $14,727.8M (+13.0%); Health Care Premiums: 12,588.4 (+14.2%); Operating Expenses: $2,714.7M (+17.8%); Operating Expense Ratio: 18.4% (+4.0%); Operating Income: $638.6M (+5.7%); Net Income: $594.5M (+14.6%); EPS: $1.67 (+21.0%).
- Medical Membership: 23,574 (+2.0%); Commercial: 19,893 (+2.0%); Medicare Advantage: 1,135 (+2.0%); Medicare Supplement: 448 (+3.2%); Medicaid: 2,098 (+2.1%).
- Medical Benefit Ratios (MBRs): Commercial: 81% (+0.6%); Government: 84% (-3.4%); Healthcare: 82.3% (-1.0%).
- 2014 Guidance: Operating Earnings Per Share of $6.60 - $6.70 from $6.45 - $6.60.
Oct. 28, 2014, 9:30 AM
- From this morning's call:
- We continue to actively examine our experience for an uptick in utilization, specifically towards the newly approved all oral hepatitis seed treatments.
- We also continue to closely monitor the outpatient category, particularly emergency department usage.
- As we noted in September, the pharmacy category remains pressured, and the outpatient category continues to run towards the high end of our projected range.
- But our inpatient physician and ancillary categories remain well-behaved.
- Based on our year-to-date experience and revised full-year outlook, we currently project that Aetna's standalone 2014 commercial medical cost trend will now be in the middle- to upper-end of our original projected range of 6% to 7%.
Oct. 28, 2014, 6:12 AM
Oct. 27, 2014, 5:30 PM
- ACI, AET, AGCO, AIXG, ALR, AME, AMTD, AN, AXE, BP, CAS, CIT, CMI, CNC, CNX, COH, CPLA, CRY, CVLT, CYNO, DD, DIN, ECL, ENTG, FCX, FDP, FLWS, FMER, GLPI, GLW, HCA, HMC, HOT, HRS, ICON, IIVI, IPGP, LH, MDSO, MLM, MMC, MSM, MSO, MWV, NBL, NCI, NVS, PCAR, PCG, PES, PFE, PH, POR, RDWR, SAIA, SAVE, SCHN, SCOR, SHW, SIRI, SNCR, ST, SYRG, TECH, TKR, TRW, TTS, TWI, UBS, UTHR, VDSI, VRTS, VSH, WAB, WHR, XYL
Oct. 23, 2014, 3:14 PM
- "I am as optimistic as I've been in a long time," says Don Wordell, noting the pull back in energy prices is a big economic stimulus. His RidgeWorth Mid-Cap Value Fund (MUTF:SAMVX) has topped 97% of peers over the last decade, and the $3.9B fund has returned 2.2% YTD - slightly ahead of the category average.
- His top five picks: SanDisk (NASDAQ:SNDK) is off more than 10% over the last month, but demand for its products is strong and growing. Cigna (NYSE:CI) and Aetna (NYSE:AET) stand to profit as hiring picks up, and with it more people into the healthcare system. Baker Hughes (NYSE:BHI) has been especially beaten down along with the price of oil, but Wordell says this hasn't caused companies to scale back production plans. OshKosk (NYSE:OSK) has been weighed on by sluggish commercial construction, but Wordell says it's about to pick up.
Oct. 14, 2014, 3:31 PM
- Global growth, foreign-exchange, oil, and small caps are the subject of every client inquiry, says David Kostin. His team's recommendation: Buy "American exceptionalism."
- In Kostin's view, U.S. economy and corporate fundamentals are still strong, with economic growth expected by Goldman economists to be 3.2% next year, the fastest expansion since 2005. Europe is expected to grow just 1%.
- What his team likes are those stocks of companies which have a high proportion of domestic sales, plus sectors like Consumer Staples (XLP -0.1%) and Discretionary (XLY +0.7%) which stand to benefit from lower oil prices (plunging again today).
- As for small caps (IWM +0.9%), Kostin is wary, noting downward earnings revisions have boosted small cap P/E ratios even as prices have declined.
- The list of S&P 500 names capturing two or more of Kostin's themes: GT, GM, PCLN, AMZN, CMCSA, LOW, DG, TSN, ADM, CVS, AVP, WAG, PXD, HAL, JPM, BAC, SCHW, PNC, MS, C, GNW, LNC, MET, THC, AET, UNH, ESRX, HUM, WLP, BIIB, GILD, DAL, CMI, FLR, CRM, JBL, MA, FB, MU, FSLR, VMC, MON, T.
Sep. 19, 2014, 2:27 PM
Jul. 29, 2014, 6:01 AM
Jul. 28, 2014, 5:30 PM
- ACI, AET, AGCO, AIXG, AKS, ALLY, AMAG, AMG, ARW, AUDC, AVX, AXE, BP, CARB, CAS, CNX, CPLA, CRS, CVLT, CYNO, DIN, DSX, ECL, ENTG, ETN, ETR, FDP, FIS, FSS, GLT, GLW, GNC, GTI, HCA, HMC, HRS, HW, ICON, IP, IPGP, ITW, KLIC, LVLT, MDC, MDSO, MDXG, MHFI, MLM, MMC, MRK, MSO, NCI, NEE, NLSN, NMM, NOV, NYT, OSK, PCAR, PFE, POR, RAI, RYN, SAVE, SIRI, SNCR, ST, TLM, TRW, UAM, UBS, UBSI, UDR, UPS, UTHR, VSH, WDR, WM, WYNN, XYL, YNDX
Jul. 25, 2014, 11:05 AM| 2 Comments
Jul. 3, 2014, 11:07 AM
- Saying that most custom-mixed medicines are either ineffective or overpriced, pharmacy benefit manager Express Scripts (ESRX +0.6%) plans to drop coverage for 1,000 drug ingredients found in compounded meds. The company states that the move will reduce employers' spending on compounded prescriptions by 95%. Express Scripts SVP Glen Stettin says, "What we are eliminating is, pure and simple, wasteful spending. These drugs are being used when there are other things available that are already approved by the FDA and are less expensive." The cuts will take effect on September 15, 2014 unless customers specifically ask to continue paying for them. Firms who want to opt out of the cuts must notify ESRX by Thursday (not sure if this means today).
- Predictably, compounding pharmacists lack enthusiasm for the move saying that it will deprive patients of much-needed medications.
- Related tickers: (UNH +0.7%) (CTRX +0.4%) (BIOS -0.2%) (WLP -0.7%) (AET +0.3%) (CI +0.6%) (HUM +0.2%) (CNC) (WCG +0.3%) (MOH +1.4%) (MGLN +0.5%)
AET vs. ETF Alternatives
Aetna Inc. is a health care benefit company, which offers traditional and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans.
Other News & PR